Last Posted: Aug 31, 2018
- New Developments in Ovarian Cancer Treatment Are Showing Promise
A Park, Time, August 28, 2018 - Differences Among a Modern Cohort of BRCA Mutation Carriers Choosing Bilateral Prophylactic Mastectomies Compared to Breast Surveillance.
Gilbert Elizabeth et al. Annals of surgical oncology 2017 Oct 24(10) 3048-3054 - Germline BRCA1/BRCA2 mutations among high risk breast cancer patients in Jordan.
Abdel-Razeq Hikmat et al. BMC cancer 2018 18(1) 152 - Association of Breast and Ovarian Cancers With Predisposition Genes Identified by Large-Scale Sequencing.
Lu Hsiao-Mei et al. JAMA oncology 2018 Aug - Genetic Testing for Cancer Lacking for Women on Medicare: Study
Health Day, August 17, 2018 - Hereditary Breast and Ovarian Cancer Testing in the Genomic Era.
Greville-Heygate Stephanie L et al. JAMA oncology 2018 Aug - Approaches to Identify and Care for Individuals with Inherited Cancer Syndromes (U01 Clinical Trial Required)
NCI Moonshot Funding Announcement, August 10, 2018 - BRCA1 and BRCA2 Testing in Medically Underserved Medicare Beneficiaries With Breast or Ovarian Cancer
AL Gross et al, JAMA, August 14, 2018 - Fertility preservation in BRCA-mutated women: when and how?
Grynberg Michaël et al. Future oncology (London, England) 2018 Feb 14(5) 483-490 - Knowledge Level and Educational Needs of Turkish Oncology Nurses Regarding the Genetics of Hereditary Breast and Ovarian Cancer.
Seven Memnun et al. Journal of continuing education in nursing 2017 Dec 48(12) 570-576
.png)
No hay comentarios:
Publicar un comentario